0000807882-26-000042
SEC filingJack in the Box Inc. reported mixed Q1 2026 results with revenues of $349.5 million and earnings from continuing operations of $14.4 million ($1.00 per share). However, the company recorded a net loss of $2.5 million (-$0.00 per share) due to losses from discontinued operations of $16.8 million. Operating performance was solid with earnings from operations of $46.6 million, representing a 13.3% operating margin. The company generated $30.5 million in operating cash flow but used $88.5 million in cash from continuing operations overall. The balance sheet shows total assets of $2.02 billion against stockholders' deficit of $936.0 million, with significant long-term debt of $1.56 billion and operating lease liabilities of $1.04 billion. Cash and restricted cash totaled $81.8 million at period end.
Jack in the Box Inc. reported Q1 2026 financial results for the period ending January 18, 2026. The company generated revenues of $349.5 million with earnings from continuing operations of $14.4 million ($1.00 per share). However, the company recorded a net loss of $2.5 million (-$0.00 per share) due to losses from discontinued operations of $16.8 million. Operating performance showed earnings from operations of $46.6 million on total operating costs and expenses of $302.9 million. The company's operating margin was 13.3%. Earnings before income taxes were $21.3 million, with income tax expense of $6.9 million. No quarterly or year-over-year comparisons are provided in the source data.
The filing does not provide segment breakdown, geographic mix, or specific growth drivers for revenue. The total revenue figure of $349.5 million represents the company's consolidated top-line performance for the quarter. No further disaggregation of revenue by business segment, product line, or geographic region is disclosed in the provided data. The XBRL data shows line items for company restaurant sales, franchise royalties and other, and franchise contributions for advertising and other services, but all are marked as N/A with no values provided.
The company achieved an operating margin of 13.3% based on earnings from operations of $46.6 million on revenues of $349.5 million. Major cost components included food and packaging ($39.2 million), payroll and employee benefits ($46.6 million), occupancy and other ($24.8 million), franchise occupancy expenses ($66.3 million), franchise support and other costs ($3.8 million), selling, general and administrative expenses ($37.0 million), and depreciation and amortization ($13.6 million). Other operating expenses showed a net benefit of $8.1 million. Gross profit is not separately disclosed in the provided data, so gross margin cannot be calculated.
The company generated $30.5 million in cash from operating activities, with key adjustments including depreciation and amortization of $13.6 million, deferred income taxes of $9.3 million, and share-based compensation expense of $4.2 million. Investing activities used $5.9 million primarily for purchases of property and equipment ($23.2 million), partially offset by proceeds from asset sales. Financing activities used $113.2 million mainly for principal repayments on debt ($112.3 million). Continuing operations used $88.5 million in cash overall. The balance sheet shows total assets of $2.02 billion, with current assets of $232.2 million including cash ($72.0 million) and restricted cash ($27.4 million). Total liabilities are $2.96 billion, including long-term debt of $1.56 billion and operating lease liabilities of $1.04 billion, resulting in stockholders' deficit of $936.0 million.
The provided filing data does not include management guidance, strategic priorities, or specific risk factors. No forward-looking statements, earnings guidance, or strategic initiatives are disclosed in the XBRL financial data or document content provided. The analysis is limited to the historical financial results for Q1 2026 as presented in the 10-Q filing. Investors should refer to the complete filing document for any management discussion and analysis, risk factors, or forward-looking statements that may be included in sections not provided in this data extract.